Related Experiment Video
Updated: Aug 2, 2026

Performing Vaginal Lavage, Crystal Violet Staining, and Vaginal Cytological Evaluation for Mouse Estrous Cycle Staging Identification
Published on: September 15, 2012
Is cytology required for a hematuria evaluation?
Chris A Hofland1, Albert J Mariani
1Department of Urology, Kaiser Medical Center, Honolulu, 96819, USA.
Urine cytology can be crucial for diagnosing transitional cell carcinoma (TCC) in patients with hematuria. Current guidelines using risk factors would have identified all patients for whom cytology provided key diagnostic information.
Area of Science:
- Urology
- Oncology
- Diagnostic Cytopathology
Background:
- The diagnostic utility of urine cytology for hematuria evaluation is debated.
- Current guidelines recommend urine cytology selectively based on transitional cell carcinoma (TCC) risk factors.
Observation:
- This study retrospectively reviewed 1,000 patients with hematuria evaluated between 1976 and 1985.
- The analysis focused on whether urine cytology provided unique or supportive information for TCC diagnosis.
Findings:
- Urine cytology was the sole diagnostic support for TCC in 4 patients.
- The test demonstrated 55% sensitivity and 99.3% specificity.
- The cost of unique diagnostic information from cytology was $8,367 (2002 Medicare rates).
Implications:
- Urine cytology plays a significant role in hematuria assessment.
- Risk-factor-based selection for cytology aligns with current best practices.
- Cost-effectiveness of urine cytology is comparable to other diagnostic methods like cystoscopy.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urine Studies I: Urinalysis
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies VI: Voiding Cystourethrography and Cystography
Urologic Endoscopic Procedure: Cystoscopic Examination
Urine Studies II: Urine Culture and Sensitivity Test

